SCHEMBL4907247

SCHEMBL4907247

O=C(O)c1ccccc1Oc1ncccc1NS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.79

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 16/20 0.79
CCR1 P32246 3/20 0.73
CYP1A2 P05177 2/20 0.64
CYP3A4 P08684 2/20 0.64
CYP2D6 P10635 2/20 0.64
CYP2C9 P11712 2/20 0.64
CYP2C19 P33261 2/20 0.64
CCR4 P51679 2/20 0.64
CCR5 P51681 2/20 0.64
ALDH1A1 P00352 2/20 0.63
KMT2A Q03164 2/20 0.63
POLB P06746 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
KCNH2 Q12809 1/20 0.56
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4910659 0.89 CCR2 (1.00) CCR2CCR1CYP1A2CYP3A4CYP2D6
SCHEMBL4912539 0.87 CCR2 (0.83) CCR2CCR1CYP1A2CYP3A4CYP2D6
SCHEMBL4902621 0.83 CCR2 (0.67) CCR2CCR1CYP1A2CYP3A4CYP2D6
SCHEMBL5666655 0.80 CCR2 (0.83) CCR2CCR1CYP1A2CYP3A4CYP2D6
SCHEMBL12200779 0.78 CCR2 (0.73) CCR2CCR1ALDH1A1KMT2APOLB
SCHEMBL4908265 0.78 CCR2 (1.00) CCR2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4903026 0.77 CCR2 (0.67) CCR2CCR1CYP1A2CYP3A4CYP2D6
SCHEMBL492321 0.76 TSHR (0.68) CCR2CCR1ALDH1A1KMT2AKDM4E
SCHEMBL3113839 0.76 KMT2A (0.77) ALDH1A1KMT2APOLBL3MBTL1KDM4E
SCHEMBL4913269 0.76 CCR2 (0.82) CCR2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 CCR2 1/4885CCR1 2/4885CYP1A2 898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.